Clinical Trials Directory

Trials / Unknown

UnknownNCT01637688

Growth and Plasma Amino Acids in Infants With CMPA and Treated With a Newly Innovated Amino Acid Formula

Growth and Plasma Amino Acid Levels in Infants With Cow's Milk Protein Allergy and Treated With a Newly Innovated Amino Acid Formula (NAAF) Compared to a Commercial Amino Acid Formula (AAF)

Status
Unknown
Phase
Study type
Observational
Enrollment
81 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
1 Week – 6 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.

Detailed description

Severe cases of cow's milk protein allergy are treated with the amino acid formula. The amino acid formula is composed of essential and non-essential amino acids, vegetable oils with or without MCT oil, and glucose polymer from various carbohydrate sources. Such formula is also fortified by minerals, trace elements,and vitamins.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTComparison of treatment with different amino acid formulasGrowth and amino acid status of a newly innovated amino acid formula (NAAF) and a commercial amino acid formula (AAF)

Timeline

Start date
2013-04-01
Primary completion
2023-06-30
Completion
2023-07-31
First posted
2012-07-11
Last updated
2023-03-24

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01637688. Inclusion in this directory is not an endorsement.